Literature DB >> 21071513

The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Dan Xin1, Beatriz E Rendon, Ming Zhao, Millicent Winner, Arlixer McGhee Coleman, Robert A Mitchell.   

Abstract

The cytokine/growth factor, macrophage migration inhibitory factor (MIF), contributes to pathologies associated with immune, inflammatory, and neoplastic disease processes. Several studies have shown an important contributing role for MIF-dependent COX-2 expression in the progression of these disorders. We now report that the MIF homologue, D-dopachrome tautomerase (D-DT), is both sufficient and necessary for maximal COX-2 expression in colorectal adenocarcinoma cell lines. D-DT-dependent COX-2 transcription is mediated in part by β-catenin protein stabilization and subsequent transcription. Also contributing to D-DTs regulation of COX-2 expression are the activities of both c-jun-N-terminal kinase and the MIF-interacting protein, Jab1/CSN5. Interestingly, D-DT-dependent β-catenin stabilization is regulated by COX-2 expression, suggesting the existence of an amplification loop between COX-2- and β-catenin-mediated transcription in these cells. Because both COX-2- and β-catenin-mediated transcription are important contributors to colorectal cancer (CRC) disease maintenance and progression, these findings suggest a unique and novel regulatory role for MIF family members in CRC pathogenesis. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071513      PMCID: PMC3075601          DOI: 10.1158/1541-7786.MCR-10-0101

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  41 in total

1.  Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

Authors:  Cédric Carli; Christine N Metz; Yousef Al-Abed; Paul H Naccache; Ali Akoum
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

Review 2.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

3.  Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor.

Authors:  Beatriz E Rendon; Thierry Roger; Ivo Teneng; Ming Zhao; Yousef Al-Abed; Thierry Calandra; Robert A Mitchell
Journal:  J Biol Chem       Date:  2007-08-20       Impact factor: 5.157

4.  A two-step model for colon adenoma initiation and progression caused by APC loss.

Authors:  Reid A Phelps; Stephanie Chidester; Somaye Dehghanizadeh; Jason Phelps; Imelda T Sandoval; Kunal Rai; Talmage Broadbent; Sharmistha Sarkar; Randall W Burt; David A Jones
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

5.  Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas.

Authors:  R J Cuthbert; J M Wilson; N Scott; P L Coletta; M A Hull
Journal:  Eur J Cancer       Date:  2009-03-09       Impact factor: 9.162

6.  Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.

Authors:  Kyu Lim; Chang Han; Lihong Xu; Kumiko Isse; Anthony J Demetris; Tong Wu
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

Review 7.  Prognostic and therapeutic implications of Apc mutations in colorectal cancer.

Authors:  A J Quyn; R J C Steele; F A Carey; I S Näthke
Journal:  Surgeon       Date:  2008-12       Impact factor: 2.392

8.  Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.

Authors:  Monica M Bertagnolli; Craig J Eagle; Ann G Zauber; Mark Redston; Aurora Breazna; Kyungmann Kim; Jie Tang; Rebecca B Rosenstein; Asad Umar; Donya Bagheri; Neal T Collins; John Burn; Daniel C Chung; Thomas Dewar; T Raymond Foley; Neville Hoffman; Finlay Macrae; Ronald E Pruitt; John R Saltzman; Bruce Salzberg; Thomas Sylwestrowicz; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31

9.  Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration.

Authors:  Wolfram Goessling; Trista E North; Sabine Loewer; Allegra M Lord; Sang Lee; Cristi L Stoick-Cooper; Gilbert Weidinger; Mark Puder; George Q Daley; Randall T Moon; Leonard I Zon
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

10.  Macrophage migration inhibitory factor promotes colorectal cancer.

Authors:  Xing-Xiang He; Ken Chen; Jun Yang; Xiao-Yu Li; Huo-Ye Gan; Cheng-Yong Liu; Thomas R Coleman; Yousef Al-Abed
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

View more
  22 in total

Review 1.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

2.  The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).

Authors:  Melanie Merk; Swen Zierow; Lin Leng; Rituparna Das; Xin Du; Wibke Schulte; Juan Fan; Hongqi Lue; Yibang Chen; Huabao Xiong; Frederic Chagnon; Jürgen Bernhagen; Elias Lolis; Gil Mor; Olivier Lesur; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-04       Impact factor: 11.205

3.  Discovery of a startling star: chemotaxis and chemotactic inhibition by starfish MIFs.

Authors:  Omar El Bounkari; Jürgen Bernhagen
Journal:  Immunol Cell Biol       Date:  2016-04       Impact factor: 5.126

4.  Autophagic flux is essential for the downregulation of D-dopachrome tautomerase by atractylenolide I to ameliorate intestinal adenoma formation.

Authors:  Lu Li; Linlin Jing; Junjiang Wang; Wenjuan Xu; Xianling Gong; Yiye Zhao; Ye Ma; Xueqing Yao; Xuegang Sun
Journal:  J Cell Commun Signal       Date:  2018-01-24       Impact factor: 5.782

5.  Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.

Authors:  Vinay Pasupuleti; Weinan Du; Yashi Gupta; I-Ju Yeh; Monica Montano; Cristina Magi-Galuzzi; Scott M Welford
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

Review 6.  Stromal-dependent tumor promotion by MIF family members.

Authors:  Robert A Mitchell; Kavitha Yaddanapudi
Journal:  Cell Signal       Date:  2014-09-30       Impact factor: 4.315

7.  Chemogenomic study of gemcitabine using Saccharomyces cerevisiae as model cell-molecular insights about chemoresistance.

Authors:  Lucas de Sousa Cavalcante; Tales A Costa-Silva; Tiago Antônio Souza; Susan Ienne; Gisele Monteiro
Journal:  Braz J Microbiol       Date:  2019-09-12       Impact factor: 2.476

8.  Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury.

Authors:  Maor Sauler; Yi Zhang; Jin-Na Min; Lin Leng; Peiying Shan; Scott Roberts; William L Jorgensen; Richard Bucala; Patty J Lee
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

9.  Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.

Authors:  Stephanie E Brock; Beatriz E Rendon; Kavitha Yaddanapudi; Robert A Mitchell
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

10.  Two macrophage migration inhibitory factors regulate starfish larval immune cell chemotaxis.

Authors:  Ryohei Furukawa; Kana Tamaki; Hiroyuki Kaneko
Journal:  Immunol Cell Biol       Date:  2016-02-02       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.